SHARES NEWS & ANALYSIS
- AbbVie Inc (2)
- GlaxoSmithKline PLC (2)
- Indivior PLC (2)
- Reckitt Benckiser Group PLC (2)
- Shire PLC (2)
- Actavis PLC (1)
- AstraZeneca PLC (1)
- Circassia Pharmaceuticals PLC (1)
- Dechra Pharmaceuticals PLC (1)
- Genus PLC (1)
27 February 2015Hutchison China MediTech upped its spending on clinical trials last year - at the expense of profitability.
27 February 2015Circassia is gearing up to launch its cat allergy treatment in the lucrative US allergy market.
24 February 2015Genetics specialist Genus insists its full-year performance won't be hurt by turbulence in Russia
24 February 2015Dechra Pharmaceuticals enjoyed a strong six months despite strong currency headwinds and curbs on antibiotic prescriptions in Europe.
17 February 2015Sinclair IS Pharma (SPH) is reviewing a number of options to transform the group's future
13 February 2015Shire's 2014 was marked by a failed takeover bid, but its prospects as a standalone company are solid.
11 February 2015Newly-independent pharma group Indivior (INDV) has released its first set of results since demerging from Reckitt Benckiser (RB.)
10 February 2015Vernalis has changed its financial year-end as it waits for US regulators to approve a new product
06 February 2015Full-year results for pharma giant AstraZeneca don't look good, but the City remains optimistic about the group's long-term future.
05 February 2015The drugs giant is looking forward to a better year after sluggish sales and a corruption drama hindered progress in 2014
02 February 2015Little is known about Reckitt Benckiser's pharma spin-off Indivior, which was only demerged in December
02 February 2015Shire will want to put AbbVie's failed takeover bid well and truly behind it when it reports results next week.